SCHEMBL25063751

SCHEMBL25063751

CC(C)C(=O)COCC(F)C(F)COc1ccc(C(C)C)c(C(F)(F)F)c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
S1PR1 P21453 1/20 0.36
KDM4E B2RXH2 1/20 0.34
KMT2A Q03164 1/20 0.34
NOTUM Q6P988 1/20 0.34
RORC P51449 1/20 0.34
MAOA P21397 1/20 0.34
MAOB P27338 1/20 0.34
AR P10275 1/20 0.34
EPHX2 P34913 3/20 0.33
LMNA P02545 2/20 0.33
MAPT P10636 1/20 0.33
THRA P10827 1/20 0.33
THRB P10828 1/20 0.33
RAB9A P51151 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
SRD5A2 P31213 1/20 0.33
FKBP1A P62942 1/20 0.33
HPGD P15428 1/20 0.33
GPR88 Q9GZN0 1/20 0.32
PPARD Q03181 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25063890 0.86 PPARG (0.38) S1PR1KDM4EKMT2ANOTUMRORC
SCHEMBL24935669 0.84 THRA (0.41) S1PR1NOTUMRORCTHRATHRB
SCHEMBL25063888 0.80 KDM4E (0.36) S1PR1KDM4EKMT2ANOTUMRORC
SCHEMBL25063893 0.78 RAB9A (0.44) KDM4EKMT2ALMNARAB9ASMN1; SMN2
SCHEMBL5514977 0.76 AGER (0.51) LMNAMAPTTHRATHRBSMN1; SMN2
SCHEMBL24935232 0.75 PPARD (0.38) KDM4EKMT2AMAOAMAOBEPHX2
SCHEMBL24935779 0.74 AR (0.36) KDM4EKMT2AMAOAMAOBAR
SCHEMBL4547952 0.74 KMT2A (0.44) KMT2ARORCARMAPTSMN1; SMN2
SCHEMBL12040801 0.73 MAPK1 (0.48) KDM4EKMT2AARMAPTSMN1; SMN2
SCHEMBL21725512 0.73 NQO1 (0.43) KDM4EKMT2ANOTUMRORCAR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230054270-A1 BIFUNCTIONAL COMPOUND, PREPARATION METHOD THEREFOR, AND USE THEREOF SUZHOU KINTOR PHARMACEUTICALS, INC. (CN) 2023-02-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230054270-A1 BIFUNCTIONAL COMPOUND, PREPARATION METHOD THEREFOR, AND USE THEREOF AR, SHBG, NR5A1 S1PR1 3636/4885KDM4E 2096/4885KMT2A 1807/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.